Trial intelligence / Profile preview

Time-of-day influenza vaccination in adults aged 60-85 years

NL-OMON58946Phase 4Completed

Sponsor
National Institute for Public Health and the Environment
Start
Sep 2024
Countries
1
01

Overview

Phase 4, randomised, open-label trial in influenza (2 arms), sponsored by National Institute for Public Health and the Environment. Started Sep 2024; status: completed.

02

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON58946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call